Viewing Study NCT07167693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-01-29 @ 3:47 AM
Study NCT ID: NCT07167693
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-11
First Post: 2025-09-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Sponsor: David K Carroll
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes (DM) View
None Diabetic Ketoacidosis View
None Ketosis Prone Diabetes View
None Hyperglycaemia (Diabetic) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Arginine hydrochloride View
None Arginine View
None R-Gene 10 View
None Insulin secretagogue View
None Endogenous insulin secretion View
None C-peptide View
None C-peptide to glucose ratio View
None Type 2 ketosis-prone diabetes (T2KPD) View
None Flatbush diabetes View
None Ketosis-prone diabetes (KPD) View
None Hyperglycemic crisis View
None Nitric oxide (NO) View
None Global arginine bioavailability ratio (GABR) View
None Mitochondrial function View